Reminder to BioAge Investors: Pending Class Action Lawsuit with Levi & Korsinsky
Investors in BioAge have a deadline of March 10, 2025, to participate in a class action lawsuit organized by Levi & Korsinsky. The lawsuit aims to hold BioAge accountable for potential violations of federal securities laws. If you have suffered losses by investing in BioAge between May 17, 2021, and November 18, 2021, you may be eligible to join this legal action.
The complaint against BioAge alleges that the company made misleading statements regarding its business prospects. Specifically, BioAge is accused of exaggerating the potential of its drug candidate, BGE-175, to increase lifespan and achieve rejuvenation. These statements allegedly inflated the company’s stock price, misleading investors about the true risks associated with BioAge’s operations.
As a result of these alleged misrepresentations, BioAge’s stock price saw a significant decline following the disclosure of the truth. Investors who purchased BioAge shares during the specified time frame suffered financial losses. The class action lawsuit seeks to recover damages for these investors and hold BioAge accountable for its actions.
Investors who wish to participate in the class action lawsuit must act before the lead plaintiff deadline of March 10, 2025. Those who purchased BioAge stock between May 17, 2021, and November 18, 2021, may be eligible to join the legal action. By becoming a part of the lawsuit, investors can seek to recover their losses and potentially receive compensation for damages suffered as a result of BioAge’s alleged securities law violations.
Participating in a class action lawsuit offers investors the opportunity to hold companies accountable for misleading statements and potential violations of securities laws. By joining together in a legal action, investors can seek justice and ensure that companies are held responsible for their actions. If you have suffered financial losses due to investing in BioAge during the specified time frame, participating in the class action lawsuit may be a way to seek recourse for your losses.
Investors interested in joining the class action lawsuit against BioAge should act promptly to meet the upcoming deadline. By taking action before March 10, 2025, investors can become part of the legal effort to hold BioAge accountable for its alleged misconduct. Don’t miss this opportunity to seek justice and potentially recover losses incurred as a result of investing in BioAge. Act now to ensure your voice is heard in this important legal action.
